UrSure has a total of 12 patents globally, out of which no patents have been granted. Of these 12 patents, more than 75% patents are active. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of UrSure.
UrSure was founded in 2015. UrSure produces medical devices that track and enhance drug adherence. It provides diagnostic testing, medication adherence, public health, social impact, healthcare, and medical devices.
Do read about some of the most popular patents of UrSure which have been covered by us in this article and also you can find UrSure patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over UrSure patent portfolio.
How many patents does UrSure have?
UrSure has a total of 12 patents globally. These patents belong to 3 unique patent families. Out of 12 patents, 9 patents are active.
How Many Patents did UrSure File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
| Year of Patents Filing or Grant | UrSure Applications Filed | UrSure Patents Granted |
| 2021 | 1 | – |
| 2020 | 3 | – |
| 2018 | 6 | – |
| 2017 | 2 | – |
How many UrSure patents are Alive/Dead?
Worldwide Patents
How Many Patents did UrSure File in Different Countries?
Countries in which UrSure Filed Patents
| Country | Patent |
| Japan | 1 |
| Indonesia | 1 |
| United States Of America | 1 |
| Canada | 1 |
| India | 1 |
| China | 1 |
| Singapore | 1 |
| Europe | 1 |
| Australia | 1 |
| Hong Kong (S.A.R.) | 1 |
Where are Research Centers of UrSure Patents Located?
The Research Centers of UrSure Patents is the United States of America.
List of UrSure patents
| UrSure Patents | Title |
| EP3695225A4 | Products And Methods For Monitoring Adherence To Nucleoside Reverse Transcriptase Inhibitor Therapy |
| CN111727372A | Products And Methods For Monitoring Adherence To Nucleoside Reverse Transcriptase Inhibitor Therapy |
| AU2018347704A1 | Products And Methods For Monitoring Adherence To Nucleoside Reverse Transcriptase Inhibitor Therapy |
| CA3079140A1 | Products And Methods For Monitoring Adherence To Nucleoside Reverse Transcriptase Inhibitor Therapy |
| JP2020536588A5 | Products And Methods For Compliant Monitoring Of Nucleoside Reverse Transcriptase Inhibitor Therapy |
| HK40037026A | Products And Methods For Monitoring Adherence To Nucleoside Reverse Transcriptase Inhibitor Therapy |
| ID2020PID03976A | Products And Methods For Monitoring Compliance In Nucleocides Return Transcription Inhibitor Therapy |
| IN202017019616A | Products And Methods For Monitoring Adherence To Nucleoside Reverse Transcriptase Inhibitor Therapy |
| SG11202003318QA | Products And Methods For Monitoring Adherence To Nucleoside Reverse Transcriptase Inhibitor Therapy |
| US20200200735A9 | System And Method For Detecting Therapeutic Agents To Monitor Adherence To A Treatment Regimen |
| WO2020205897A1 | System And Method For Detecting Therapeutic Agents To Monitor Adherence To A Treatment Regimen |
| WO2017147186A1 | System And Method For Detecting Therapeutic Agents To Monitor Adherence To A Treatment Regimen |
What are UrSure key innovation segments?
What Technologies are Covered by UrSure?
The chart below distributes patents filed by UrSure